scispace - formally typeset
R

Ruediger Stendel

Researcher at Charité

Publications -  22
Citations -  4661

Ruediger Stendel is an academic researcher from Charité. The author has contributed to research in topics: Taurolidine & Neoplastic cell. The author has an hindex of 11, co-authored 22 publications receiving 3750 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Efficacy and safety of a collagen matrix for cranial and spinal dural reconstruction using different fixation techniques.

TL;DR: The collagen matrix is an effective and safe cranial and spinal dural substitute that can be used even in cases of an existing local infection.
Journal ArticleDOI

Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.

TL;DR: G gelatin-thrombin matrix appears to be an effective, easy-to-use, and readily available hemostatic agent for cranial neurosurgery and combined with fibrinogen is recommended in special situations.
Journal ArticleDOI

Injection therapy of lumbar facet syndrome: a prospective study

TL;DR: The clinical effect is limited, and the best time for additional repetitive injection according to this protocol after 3 months is recommended, and this protocol is safe, effective, and easy to perform.
Journal ArticleDOI

Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.

TL;DR: Taurolidine displayed a stable pattern of derivatives in plasma in vitro, whereas in whole blood, a time- and concentration-dependent conversion was apparent, and in patients, the calculated average t Taurolidine plasma concentration was in the antineoplastic-effective concentration range.